⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IONS News
Ionis Pharmaceuticals, Inc. Common Stock
Next Generation Drug Conjugates Market Expected to Reach USD 42.55 Billion by 2035 | MarketsandMarkets™
globenewswire.com
AZN
NVS
ALNY
GILD
ABBV
IONS
SNY
Form 8-K
sec.gov
IONS
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX
Form 8-K
sec.gov
IONS
Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directors
businesswire.com
IONS
Form 8-K
sec.gov
IONS
ATTR Early-Career Research Forum Opens National Call for Abstracts; Two $100,000 Wiesman Awards to Be Granted
prnewswire.com
AZN
IONS
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
businesswire.com
IONS
New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia USA - English USA - English
prnewswire.com
IONS
New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia
prnewswire.com
IONS